AUPH logo

Aurinia Pharmaceuticals (AUPH) Retained earnings

annual retained earnings:

-$936.57M+$5.75M(+0.61%)
December 31, 2024

Summary

  • As of today (May 25, 2025), AUPH annual retained earnings is -$936.57 million, with the most recent change of +$5.75 million (+0.61%) on December 31, 2024.
  • During the last 3 years, AUPH annual retained earnings has fallen by -$180.45 million (-23.86%).
  • AUPH annual retained earnings is now -17025.69% below its all-time high of -$5.47 million, reached on November 30, 1998.

Performance

AUPH Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHbalance sheet metrics

quarterly retained earnings:

-$913.23M+$23.34M(+2.49%)
March 31, 2025

Summary

  • As of today (May 25, 2025), AUPH quarterly retained earnings is -$913.23 million, with the most recent change of +$23.34 million (+2.49%) on March 31, 2025.
  • Over the past year, AUPH quarterly retained earnings has increased by +$39.84 million (+4.18%).
  • AUPH quarterly retained earnings is now -16497.47% below its all-time high of -$5.50 million, reached on February 28, 1999.

Performance

AUPH quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

AUPH Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.6%+4.2%
3 y3 years-23.9%-15.1%
5 y5 years-98.2%-64.2%

AUPH Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-23.9%+0.6%-15.1%+4.2%
5 y5-year-98.2%+0.6%-64.2%+4.2%
alltimeall time<-9999.0%+0.6%<-9999.0%+4.2%

AUPH Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$913.23M(-2.5%)
Dec 2024
-$936.57M(-0.6%)
-$936.57M(-0.2%)
Sep 2024
-
-$938.00M(-1.5%)
Jun 2024
-
-$952.35M(-0.1%)
Mar 2024
-
-$953.07M(+1.1%)
Dec 2023
-$942.32M(+9.0%)
-$942.32M(+2.9%)
Sep 2023
-
-$915.45M(+1.5%)
Jun 2023
-
-$902.00M(+1.3%)
Mar 2023
-
-$890.51M(+3.0%)
Dec 2022
-$864.30M(+14.3%)
-$864.30M(+3.1%)
Sep 2022
-
-$838.26M(+1.1%)
Jun 2022
-
-$829.27M(+4.5%)
Mar 2022
-
-$793.75M(+5.0%)
Dec 2021
-$756.12M(+31.5%)
-$756.12M(+4.6%)
Sep 2021
-
-$722.80M(+7.5%)
Jun 2021
-
-$672.54M(+7.5%)
Mar 2021
-
-$625.53M(+8.8%)
Dec 2020
-$575.16M(+21.7%)
-$575.16M(-1.8%)
Jun 2020
-
-$585.87M(+5.3%)
Mar 2020
-
-$556.34M(+17.7%)
Dec 2019
-$472.48M(+13.6%)
-$472.48M(+2.0%)
Sep 2019
-
-$463.33M(+4.3%)
Jun 2019
-
-$444.29M(+3.7%)
Mar 2019
-
-$428.39M(+3.0%)
Dec 2018
-$415.96M(+18.2%)
-$415.96M(+3.6%)
Sep 2018
-
-$401.37M(+4.8%)
Jun 2018
-
-$383.02M(+4.3%)
Mar 2018
-
-$367.32M(+4.4%)
Dec 2017
-$351.84M(+25.2%)
-$351.84M(+1.0%)
Sep 2017
-
-$348.51M(+3.9%)
Jun 2017
-
-$335.39M(+0.7%)
Mar 2017
-
-$332.99M(+18.5%)
Dec 2016
-$281.05M(+9.0%)
-$281.05M(+3.1%)
Sep 2016
-
-$272.71M(+2.8%)
Jun 2016
-
-$265.30M(+1.3%)
Mar 2016
-
-$262.02M(+1.7%)
Dec 2015
-$257.75M(+7.8%)
-$257.75M(+1.6%)
Sep 2015
-
-$253.69M(+2.1%)
Jun 2015
-
-$248.48M(+0.3%)
Mar 2015
-
-$247.75M(+3.6%)
Dec 2014
-$239.15M(+8.8%)
-$239.15M(+3.3%)
Sep 2014
-
-$231.45M(+1.1%)
Jun 2014
-
-$228.93M(+1.8%)
Mar 2014
-
-$224.92M(+2.4%)
Dec 2013
-$219.72M(+1.2%)
-$219.72M(+2.9%)
Sep 2013
-
-$213.45M(+3.1%)
Jun 2013
-
-$206.95M(-2.9%)
Mar 2013
-
-$213.04M(-1.9%)
Dec 2012
-$217.06M(+7.4%)
-$217.06M(+1.4%)
Sep 2012
-
-$214.15M(+4.2%)
Jun 2012
-
-$205.56M(-0.8%)
Mar 2012
-
-$207.20M(+2.6%)
DateAnnualQuarterly
Dec 2011
-$202.03M(-0.9%)
-$202.03M(+5.0%)
Sep 2011
-
-$192.49M(-7.7%)
Jun 2011
-
-$208.55M(-1.9%)
Mar 2011
-
-$212.68M(+4.4%)
Dec 2010
-$203.78M(+6.7%)
-$203.78M(+4.5%)
Sep 2010
-
-$195.01M(+3.0%)
Jun 2010
-
-$189.41M(-3.1%)
Mar 2010
-
-$195.38M(+2.3%)
Dec 2009
-$190.98M(+21.0%)
-$190.98M(+2.9%)
Sep 2009
-
-$185.63M(+9.6%)
Jun 2009
-
-$169.36M(+9.0%)
Mar 2009
-
-$155.34M(-1.5%)
Dec 2008
-$157.78M(-9.5%)
-$157.78M(-10.8%)
Sep 2008
-
-$176.81M(-1.9%)
Jun 2008
-
-$180.25M(+4.2%)
Mar 2008
-
-$172.96M(-0.8%)
Dec 2007
-$174.38M(+46.0%)
-$174.38M(+5.4%)
Sep 2007
-
-$165.42M(+12.3%)
Jun 2007
-
-$147.37M(+15.7%)
Mar 2007
-
-$127.38M(+6.7%)
Dec 2006
-$119.42M(+23.2%)
-$119.42M(+1.3%)
Sep 2006
-
-$117.84M(+5.4%)
Jun 2006
-
-$111.81M(+10.5%)
Mar 2006
-
-$101.15M(+4.4%)
Dec 2005
-$96.91M(+47.9%)
-$96.91M(+10.9%)
Sep 2005
-
-$87.42M(+12.5%)
Jun 2005
-
-$77.71M(+7.8%)
Mar 2005
-
-$72.10M(+10.0%)
Dec 2004
-$65.54M(+64.5%)
-$65.54M(+19.6%)
Sep 2004
-
-$54.82M(+21.8%)
Jun 2004
-
-$45.02M(+6.4%)
Mar 2004
-
-$42.30M(+6.2%)
Dec 2003
-$39.84M(+94.1%)
-$39.84M(+24.5%)
Sep 2003
-
-$32.01M(+16.6%)
Jun 2003
-
-$27.45M(+4.7%)
Mar 2003
-
-$26.21M(+27.7%)
Dec 2002
-$20.52M(+3.4%)
-$20.52M(+17.3%)
Sep 2002
-
-$17.50M(-16.4%)
Jun 2002
-
-$20.92M(-4.4%)
Mar 2002
-
-$21.88M(+8.8%)
Dec 2001
-$19.84M(+53.8%)
-
Aug 2001
-
-$20.11M(+11.0%)
May 2001
-
-$18.11M(+20.6%)
Feb 2001
-
-$15.01M(+16.4%)
Nov 2000
-$12.90M(+86.2%)
-$12.90M(+20.1%)
Aug 2000
-
-$10.74M(+17.4%)
May 2000
-
-$9.14M(+18.5%)
Feb 2000
-
-$7.72M(+11.4%)
Nov 1999
-$6.93M(+26.7%)
-$6.93M(+17.6%)
Aug 1999
-
-$5.89M(-2.5%)
May 1999
-
-$6.04M(+9.7%)
Feb 1999
-
-$5.50M
Nov 1998
-$5.47M
-

FAQ

  • What is Aurinia Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals annual retained earnings year-on-year change?
  • What is Aurinia Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals quarterly retained earnings year-on-year change?

What is Aurinia Pharmaceuticals annual retained earnings?

The current annual retained earnings of AUPH is -$936.57M

What is the all time high annual retained earnings for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high annual retained earnings is -$5.47M

What is Aurinia Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, AUPH annual retained earnings has changed by +$5.75M (+0.61%)

What is Aurinia Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of AUPH is -$913.23M

What is the all time high quarterly retained earnings for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high quarterly retained earnings is -$5.50M

What is Aurinia Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, AUPH quarterly retained earnings has changed by +$39.84M (+4.18%)
On this page